Critical Care
Bextra Withdrawn From Market
The prescription nonsteroidal anti-inflammatory drug (NSAID) Bextra (valdecoxib) is being withdrawn from the market at the request of the U.S. Food and Drug Administration, which found that the overall risk-versus-benefit profile for the drug is unfavorable. More...21 Apr 2005
In Other News
Global Project to Fight Infant Asphyxia
Pneumonia Vaccination Reduces Child Mortality
Electroacupuncture Lowers High Blood Pressure
Infusion System for Kidney Patients
New Deadly Disease Identified
Aspirin vs Warfarin to Reduce Stroke Risk
RNAi Therapeutic for Respiratory Virus
A Type of Stem Cell May Repair Hearts
Device for Stroke Rehabilitation
ICU Enteral Feeding Unsatisfactory
Specialists Improve Heart Care
Drug Improves Heart-Attack Survival
New Testing Technology for Sleep Apnea
Procedure for Stroke Patients With Migraine
IT System for Hospital Care Processes
Electrical Changes Predict Heart Failure
European Anesthesiologists Unite
Device Monitors REM Sleep
European Market for Sleep Apnea Diagnostics
Gender Bias Found in Bypass Surgery
New Therapy for Cerebral Hemorrhage
EMS Data Collection System
New Technology for Respiratory Care
HospiMedica Critical Care channel provides timely reporting on emergency medicine, intensive care, anesthesia, neonatal care, patient monitoring, respiratory care, infection control, and more hospital related subjects.







